| 101.54 0.56 (0.55%) | 07-26 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 120.38  |
1-year : | 140.61 |
| Resists | First : | 103.06 |
Second : | 120.38 |
| Pivot price | 98.45 |
|||
| Supports | First : | 95.16 |
Second : | 90.27 |
| MAs | MA(5) : | 100.04 |
MA(20) : | 96.82 |
| MA(100) : | 92.14 |
MA(250) : | 85.08 |
|
| MACD | MACD : | 2.2 |
Signal : | 1.9 |
| %K %D | K(14,3) : | 81.7 |
D(3) : | 78.3 |
| RSI | RSI(14): 66.3 |
|||
| 52-week | High : | 103.51 | Low : | 63.79 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ XBI ] has closed below upper band by 18.3%. Bollinger Bands are 7.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 103.2 - 103.58 | 103.58 - 103.89 |
| Low: | 99.92 - 100.41 | 100.41 - 100.8 |
| Close: | 100.82 - 101.56 | 101.56 - 102.16 |
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").
Wed, 10 Jul 2024
VOO vs. SPY: Which S&P 500 ETF Is Better? - GOBankingRates
Tue, 02 Jul 2024
SPY vs. VOO: Which of Warren Buffett’s ETFs Is Better? - Morningstar
Mon, 01 Jul 2024
Best SPDR ETFs Of July 2024 - Forbes
Thu, 13 Jun 2024
SPY Stock: Is It A Buy Right Now? What To Know About World's Top Index - Investor's Business Daily
Tue, 14 May 2024
How to Buy SPDR S&P 500 ETF Trust (SPY) - The Motley Fool
Mon, 13 May 2024
7 Top-Performing Equal-Weight ETFs to Buy | Investing - U.S News & World Report Money
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|